** Shares of continuous glucose-monitoring device makers Abbott ABTN and Dexcom DXCM.O rise after U.S. Health Secretary Robert F. Kennedy Jr. stated, "We're about to launch one of the biggest advertising campaigns in HHS (Health and Human Services) history to encourage Americans to use wearables."
** ABT rose 3.5% to $137.94, while DXCM jumped 7.7% to $85.99, in afternoon trading
** "We think that wearables are a key to the MAHA agenda, Making America Healthy Again and my vision is that every American is wearing a wearable within four years" - Kennedy
** Including session moves, ABT and DXCM have gained 22.1% and 10.8%, respectively, YTD
(Reporting by Puyaan Singh)
((Puyaan.Singh@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.